Human Molecular Genetics Advance Access originally published online on August 21, 2006
Human Molecular Genetics 2006 15(19):2888-2902; doi:10.1093/hmg/ddl230
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3
1 Institute for Neural Signal Transduction, ZMNH , 2 Department of Pediatrics, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany, 3 Leibniz Institute for Arteriosclerosis Research (LIFA) , 4 Department of Cardiology and Angiology , 5 Department of Medicine B, University of Münster, Germany, 6 Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, NY, USA, 7 Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy, 8 INSERM U582, Institut de Myologie, Groupe Hospitalier Pitié Salpêtrière, Paris, France and 9 Université Pierre et Marie Curie-Paris6, UMR S582, IFR14, Paris, France
* To whom correspondence should be addressed. Tel: +49 40428036650; Fax: +49 40428036643; Email: dirk.isbrandt{at}isbrandtlab.org
Received April 1, 2006; Revised July 3, 2006; Accepted August 10, 2006
ß-Adrenergic receptor-mediated cAMP or protein kinase A (PKA)-dependent modulation of cardiac potassium currents controls ventricular action potential duration (APD) at faster heart rates. HERG (KCNH2) gene mutations are associated with congenital long-QT syndrome (LQT2) and affect IKr activity, a key determinant in ventricular repolarization. Physical activity or emotional stress often triggers lethal arrhythmias in LQT2 patients. ß-Adrenergic stimulation of HERG channel activity is amplified and prolonged in vitro by the adaptor protein 14-3-3
. In LQT2 families, we identified three novel heterozygous HERG mutations (G965X, R1014PfsX39, V1038AfsX21) in the C-terminus that led to protein truncation and loss of a PKA phosphorylation site required for binding of 14-3-3. When expressed in CHO cells, the mutants produced functional HERG channels with normal kinetic properties. We now provide evidence that HERG channel regulation by 14-3-3 is of physiological significance in humans. Upon co-expression with 14-3-3, mutant channels still bound 14-3-3 but did not respond with a hyperpolarizing shift in voltage dependence as seen in wild-type channels. Co-expression experiments of wild-type and mutant channels revealed dominant-negative behavior of all three HERG mutations. Simulations of the effects of sympathetic stimulation of HERG channel activity on the whole-cell action potential suggested a role in rate-dependent control of APD and an impaired ability of mutant cardiac myocytes to respond to a triggered event or an ectopic beat. In summary, the attenuated functional effects of 14-3-3 on C-terminally truncated HERG channels demonstrate the physiological importance of coupling ß-adrenergic stimulation and HERG channel activity.
The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. C. Ahrens-Nicklas, C. E. Clancy, and D. J. Christini Re-evaluating the efficacy of {beta}-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling Cardiovasc Res, June 1, 2009; 82(3): 439 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Gong, L. Zhang, G. M. Vincent, B. D. Horne, and Z. Zhou Nonsense Mutations in hERG Cause a Decrease in Mutant mRNA Transcripts by Nonsense-Mediated mRNA Decay in Human Long-QT Syndrome Circulation, July 3, 2007; 116(1): 17 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Suto, W. Zhu, A. Chan, and G. J. Gross IKr and IKs remodeling differentially affects QT interval prolongation and dynamic adaptation to heart rate acceleration in bradycardic rabbits Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1782 - H1788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Brunelli, K. A. Cieslik, J. L. Alcorn, M. Vatta, and A. Baldini Peroxisome Proliferator-Activated Receptor-{delta} Upregulates 14-3-3{epsilon} in Human Endothelial Cells via CCAAT/Enhancer Binding Protein-{beta} Circ. Res., March 16, 2007; 100(5): e59 - e71. [Abstract] [Full Text] [PDF]
|
|